Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation

Author： Cazzola Mario   Calzetta Luigino   Page Clive P   Matera Maria Gabriella  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.10, Iss.1, 2014-01, pp. : 129-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Indacaterol entices both COPD and asthma patients

By  

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Indacaterol a breath of fresh air for COPD in Mexico

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 630, 2011-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis

By Gatti Davide  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 883-892

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines

By Lionetto Luana   Casolla Barbara   Mastropietri Fabiola   D'Alonzo Lidia   Negro Andrea   Simmaco Maurizio   Martelletti Paolo  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 8, 2012-08 ,pp. : 1043-1050

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of decitabine for the treatment of leukemia

By Bryan Jeffrey   Kantarjian Hagop   Garcia-Manero Guillermo   Jabbour Elias  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 5, 2011-05 ,pp. : 661-672

Informa Healthcare

Access to resources Recommend Favorite